Medical Home Network Expands to North Carolina and Puts Patients at Center of NC Medicaid Reform

CHICAGO, June 10, 2021 /PRNewswire/ — North Carolina Medicaid enrollees beginning July 1 will participate in managed care plans, the…

Despite Continued COVID Concerns, Virginians Appear Ready to Return to the Dentist

ROANOKE, Va., June 10, 2021 /PRNewswire/ — A new statewide survey conducted by Delta Dental of Virginia shows 35% of Virginians…

Provident Healthcare Partners Wins Three Awards at the Annual USA Middle Market Awards

BOSTON and LOS ANGELES, June 10, 2021 /PRNewswire/ — Provident Healthcare Partners was the recipient of three awards at the Annual USA Middle Market…

Neurovascular Devices/Interventional Neurology Market by Product,Pathology and User

The “Global Neurovascular Devices/Interventional Neurology Market by Product (Embolization (Coil, Flow Diverter), Stents, Balloon Occlusion Devices, Clot…

Canadian Medical Auctions Launches First Auction in Toronto, Canada

Canadian Medical Auctions, dedicated to the re-marketing and auction of surplus healthcare equipment, is delighted to…

Mirati Therapeutics to Take Part in the 42nd Annual Goldman Sachs Global Healthcare Conference

 Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will take part in a fireside chat at…

FieldLine Launches HEDscan™, a Next-Generation Device for Non-Invasive Functional Brain Imaging

FieldLine Inc., a biotech company targeting advanced brain diagnostic technology, announced today the general availability of…

Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis

Bridge Biotherapeutics (KQ288330) today announced the first patient dosing of BBT-401 in its open label, proof…

Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis

Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA)…

Vivera Pharmaceuticals Granted Allowance for ZICOH® Patent

 Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent…